Effect of bile salts on the transport of morphine-6-glucuronide in rat brain endothelial cells

Journal of Pharmaceutical Sciences

Volumn 100, Issue 4, 2011, Pages 1516-1524

  Yang, Lin ^a   Zhang, Hu ^a   Fawcett, J Paul ^a   Mikov, Momir ^a   Tucker, Ian G ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Astrocyte; Bile salt; Blood brain barrier; M6G; Permeability; RBE4 cell; Transport

Indexed keywords

12 MONOKETOCHOLATE; 3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; BILE SALT; CHOLIC ACID; DEOXYCHOLIC ACID; MORPHINE 6 GLUCURONIDE; SUCROSE; TAUROCHOLIC ACID; UNCLASSIFIED DRUG; BILE ACID; DRUG VEHICLE; MORPHINE DERIVATIVE; MORPHINE-6-GLUCURONIDE;

ANIMAL CELL; ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN CELL; CELL MEMBRANE; CELL TRANSPORT; CULTURE MEDIUM; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG TRANSPORT; DRUG UPTAKE; ENDOTHELIUM CELL; MONOLAYER CULTURE; NONHUMAN; PHYSICAL CHEMISTRY; RAT; ANIMAL; BRAIN; CELL LINE; CYTOLOGY; METABOLISM; PERMEABILITY;

ANIMALS; BILE ACIDS AND SALTS; BLOOD-BRAIN BARRIER; BRAIN; CELL LINE; ENDOTHELIAL CELLS; MORPHINE DERIVATIVES; PERMEABILITY; PHARMACEUTICAL VEHICLES; RATS;

EID: 79951930856     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22390     Document Type: Article

References (46)

1. Sharma P, Varma MV, Chawla HP, Panchagnula R. 2005. Absorption enhancement, mechanistic and toxicity studies of medium chain fatty acids, cyclodextrins and bile salts as peroral absorption enhancers. Farmaco 60(11-12):884-893.
2. Deneer VHM, Drese GB, Roemelé PEH, Verhoef JC, Lie-A-Huen L, Kingma JH, Brouwers JRBJ, Junginger HE. 2002. Buccal transport of flecainide and sotalol: Effect of a bile salt and ionization state. Int J Pharm 241(1):127-134.
3. Saettone MF, Chetoni P, Cerbai R, Mazzanti G, Braghiroli L. 1996. Evaluation of ocular permeation enhancers: In vitro effects on corneal transport of four β-blockers, and in vitro/in vivo toxic activity. Int J Pharm 142(1):103-113.
4. Mikov M, Kevresan S, Kuhajda K, Jakovljevic V, Vasovic V. 2004. 3Alpha, 7alpha-dihydroxy-12-oxo-5beta-cholanate as blood-brain barrier permeator. Pol J Pharmacol 56(3):367-371.
5. Barnes S, Gallo GA, Trash DB, Morris JS. 1975. Diagnostic value of serum bile acid estimations in liver disease. J Clin Pathol 28(6):506-509.
6. Tominaga S, Watanabe A, Tsuji T. 1991. Synergistic effect of bile acid, endotoxin, and ammonia on brain edema. Metab Brain Dis 6(2):93-105.
7. Gumbleton M, Audus KL. 2001. Progress and limitations in the use of in vitro cell cultures to serve as a permeability screen for the blood-brain barrier. J Pharm Sci 90(11):1681-1698.
8. Yamazaki D, Ohya S, Asai K, Imaizumi Y. 2007. Characteristics of the ATP-induced Ca2+-entry pathway in the t-BBEC 117 cell line derived from bovine brain endothelial cells. J Pharmacol Sci 104(1):103-107.
9. Ketabi-Kiyanvash N, Herold-Mende C, Kashfi F, Caldeira S, Tommasino M, Haefeli WE, Weiss J. 2007. NKIM-6, a new immortalized human brain capillary endothelial cell line with conserved endothelial characteristics. Cell Tissue Res 328(1):19-29.
10. Homma M, Suzuki H, Kusuhara H, Naito M, Tsuruo T, Sugiyama Y. 1999. High-affinity efflux transport system for glutathione conjugates on the luminal membrane of a mouse brain capillary endothelial cell line (MBEC4). J Pharmacol Exp Ther 288(1):198-203.
11. Cecchelli R, Berezowski V, Lundquist S, Culot M, Renftel M, Dehouck MP, Fenart L. 2007. Modelling of the blood-brain barrier in drug discovery and development. Nat Rev Drug Discov 6(8):650-661.
12. Roux F, Durieu-Trautmann O, Chaverot N, Claire M, Mailly P, Bourre JM, Strosberg AD, Couraud PO. 1994. Regulation of gamma-glutamyl transpeptidase and alkaline phosphatase activities in immortalized rat brain microvessel endothelial cells. J Cell Physiol 159(1):101-113.
13. Garcia-Garcia E, Gil S, Andrieux K, Desmaele D, Nicolas V, Taran F, Georgin D, Andreux JP, Roux F, Couvreur P. 2005. A relevant in vitro rat model for the evaluation of blood-brain barrier translocation of nanoparticles. Cell Mol Life Sci 62(12):1400-1408.
14. Yang J, Mutkus LA, Sumner D, Stevens JT, Eldridge JC, Strandhoy JW, Aschner M. 2001. Transendothelial permeability of chlorpyrifos in RBE4 monolayers is modulated by astrocyte-conditioned medium. Mol Brain Res 97(1):43-50.
15. Rist RJ, Romero IA, Chan MWK, Couraud PO, Roux F, Abbott NJ. 1997. F-actin cytoskeleton and sucrose permeability of immortalised rat brain microvascular endothelial cell monolayers: Effects of cyclic AMP and astrocytic factors. Brain Res 768(1-2):10-18.
16. Aschner M, Fitsanakis VA, dos Santos AP, Olivi L, Bressler JP. 2006. Blood-brain barrier and cell-cell interactions: Methods for establishing in vitro models of the blood-brain barrier and transport measurements. Methods Mol Biol 341:1-15.
17. Calabria AR, Weidenfeller C, Jones AR, de Vries HE, Shusta EV. 2006. Puromycin-purified rat brain microvascular endothelial cell cultures exhibit improved barrier properties in response to glucocorticoid induction. J Neurochem 97(4):922-933.
18. Blecharz KG, Drenckhahn D, Förster CY. 2008. Glucocorticoids increase VE-cadherin expression and cause cytoskeletal rearrangements in murine brain endothelial cEND cells. J Cereb Blood Flow Metab 28(6):1139-1149.
19. Schrot S, Weidenfeller C, Schäffer TE, Robenek H, Galla HJ. 2005. Influence of hydrocortisone on the mechanical properties of the cerebral endothelium in vitro. Biophys J 89(6):3904-3910.
20. Kilpatrick GJ, Smith TW. 2005. Morphine-6-glucuronide: Actions and mechanisms. Med Res Rev 25(5):521-544.
21. McCarthy KD, de Vellis J. 1980. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 85(3):890-902.
22. Booher J, Sensenbrenner M. 1972. Growth and cultivation of dissociated neurons and glial cells from embryonic chick, rat and human brain in flask cultures. Neurobiology 2(3):97-105.
23. van Crugten JT, Somogyi AA, Nation RL, Reynolds G. 1997. Concentration-effect relationships of morphine and morphine-6β-glucuronide in the rat. Clin Exp Pharmacol Physiol 24(5):359-364.
24. Stain-Texier F, Boschi G, Sandouk P, Scherrmann JM. 1999. Elevated concentrations of morphine 6-beta-d-glucuronide in brain extracellular fluid despite low blood-brain barrier permeability. Br J Pharmacol 128(4):917-924.
25. Yang L, Zhang H, Mikov M, Tucker IG. 2009. Physicochemical and biological characterization of monoketocholic acid, a novel permeability enhancer. Mol Pharm 6(2):448-456.
26. Abbott NJ, Rönnbäck L, Hansson E. 2006. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 7(1):41-53.
27. Arthur FE, Shivers RR, Bowman PD. 1987. Astrocyte-mediated induction of tight junctions in brain capillary endothelium: An efficient in vitro model. Brain Res 433(1):155-159.
28. Rubin LL, Hall DE, Porter S, Barbu K, Cannon C, Horner HC, Janatpour M, Liaw CW, Manning K, Morales J, Tanner LI, Tomaselli KJ, Bard F. 1991. A cell culture model of the blood-brain barrier. J Cell Biol 115(6):1725-1735.
29. Gaillard PJ, Voorwinden LH, Nielsen JL, Ivanov A, Atsumi R, Engman H, Ringbom C, de Boer AG, Breimer DD. 2000. Establishment and functional characterization of an in vitro model of the blood-brain barrier, comprising a co-culture of brain capillary endothelial cells and astrocytes. Eur J Pharm Sci 12(3):215-222.
30. Rist RJ, Romero IA, Chan MWK, Couraud PO, Roux F, Abbott NJ. 1997. F-Actin cytoskeleton and sucrose permeability of immortalised rat brain microvascular endothelial cell monolayers: Effects of cyclic AMP and astrocytic factors. Brain Res 768(1-2):10-18.
31. David Kobiler SL, Shlomo Shapira. 2001. Blood-brain barrier: Drug delivery and brain pathology. 1st ed. New York: Kluwer Academic Publishers.
32. Pardridge WM, Triguero D, Yang J, Cancilla PA. 1990. Comparison of in vitro and in vivo models of drug transcytosis through the blood-brain barrier. J Pharmacol Exp Ther 253(2):884-891.
33. Levin VA. 1980. Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability. J Med Chem 23(6):682-684.
34. Ohno K, Pettigrew KD, Rapoport SI. 1978. Lower limits of cerebrovascular permeability to nonelectrolytes in the conscious rat. Am J Physiol Heart Circ Physiol 4(3):H299-H307.
35. Perrière N, Yousif S, Cazaubon S, Chaverot N, Bourasset F, Cisternino S, Declèves X, Hori S, Terasaki T, Deli M, Scherrmann JM, Temsamani J, Roux F, Couraud PO. 2007. A functional in vitro model of rat blood-brain barrier for molecular analysis of efflux transporters. Brain Res 1150:1-13.
36. Parkinson FE, Hacking C. 2005. Pericyte abundance affects sucrose permeability in cultures of rat brain microvascular endothelial cells. Brain Res 1049(1):8-14.
37. Artursson P, Palm K, Luthman K. 2001. Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv Drug Delivery Rev 46(1-3):27-43.
38. Bickel U, Yoshikawa T, Pardridge WM. 2001. Delivery of peptides and proteins through the blood-brain barrier. Adv Drug Deliv Rev 46(1-3):247-279.
39. Wu D, Kang YS, Bickel U, Pardridge WM. 1997. Blood-brain barrier permeability to morphine-6-glucuronide is markedly reduced compared with morphine. Drug Metab Dispos 25(6):768-771.
40. Bourasset F, Cisternino S, Temsamani J, Scherrmann JM. 2003. Evidence for an active transport of morphine-6-beta-d-glucuronide but not P-glycoprotein-mediated at the blood-brain barrier. J Neurochem 86(6):1564-1567.
41. Lötsch J, Schmidt R, Vetter G, Schmidt H, Skarke C, Niederberger E, Geisslinger G, Tegeder I. 2002. The influence of inhibition of probenecid sensitive transporters on the central nervous system (CNS) uptake and the antinociceptive activity of morphine-6-glucuronide in rats. Neurosci Lett 329(2):145-148.
42. Lötsch J, Tegeder I, Angst MS, Geisslinger G. 2000. Antinociceptive effects of morphine-6-glucuronide in homozygous MDR1a P-glycoprotein knockout and in wildtype mice in the hotplate test. Life Sci 66(24):2393-2403.
43. Reina B, Gloria L, Moise B. 2002. Functional expression and localization of P-glycoprotein at the blood-brain barrier. Microsc Res Tech 57(5):365-380.
44. Delzenne NM, Calderon PB, Taper HS, Roberfroid MB. 1992. Comparative hepatotoxicity of cholic acid, deoxycholic acid and lithocholic acid in the rat: In vivo and in vitro studies. Toxicol Lett 61(2-3):291-304.
45. Kitazawa T, Terasaki T, Suzuki H, Kakee A, Sugiyama Y. 1998. Efflux of taurocholic acid across the blood-brain barrier: Interaction with cyclic peptides. J Pharmacol Exp Ther 286(2):890-895.
46. Roux F, Couraud PO. 2005. Rat brain endothelial cell lines for the study of blood-brain barrier permeability and transport functions. Cell Mol Neurobiol 25(1):41-58.